These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1514490)

  • 21. [Graded criteria to assess the effectiveness of anti-arrhythmia therapy in patients with ventricular tachyarrhythmia by serial electrophysiological testing].
    Borggrefe M; Breithardt G
    Z Kardiol; 1986 Feb; 75(2):70-9. PubMed ID: 3705680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced efficacy of oral sotalol for sustained ventricular tachycardia refractory to type I antiarrhythmic drugs.
    Kienzle MG; Martins JB; Wendt DJ; Constantin L; Hopson R; McCue ML
    Am J Cardiol; 1988 May; 61(13):1012-7. PubMed ID: 3129926
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Electrophysiologic profile and efficacy of intravenous dofetilide (UK-68,798), a new class III antiarrhythmic drug, in patients with sustained monomorphic ventricular tachycardia. Dofetilide Arrhythmia Study Group.
    Bashir Y; Thomsen PE; Kingma JH; Møller M; Wong C; Cobbe SM; Jordaens L; Campbell RW; Rasmussen HS; Camm AJ
    Am J Cardiol; 1995 Nov; 76(14):1040-4. PubMed ID: 7484858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Electrophysiologic and clinical factors influencing response to class IA antiarrhythmic agents in patients with inducible sustained monomorphic ventricular tachycardia.
    Gold RL; Haffajee CI; Alpert JS
    Am Heart J; 1986 Jul; 112(1):9-13. PubMed ID: 3728294
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antiarrhythmic therapy on delayed potentials detected by the signal-averaged electrocardiogram in patients with ventricular tachycardia after acute myocardial infarction.
    Denniss AR; Ross DL; Richards DA; Cody DV; Russell PA; Young AA; Uther JB
    Am J Cardiol; 1986 Aug; 58(3):261-5. PubMed ID: 3739914
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Na+ channel blockers vs class III antiarrhythmic drugs in treating sustained ventricular tachycardia: reversing and preventing as different electrophysiological mechanisms.
    Masotti CS; Pierangeli A
    Panminerva Med; 1999 Dec; 41(4):295-306. PubMed ID: 10705709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and risks of moricizine in inducible sustained ventricular tachycardia.
    Damle R; Levine J; Matos J; Greenberg S; Brooks R; Frumkin W; Goldberger J; Kadish AH
    Ann Intern Med; 1992 Mar; 116(5):375-81. PubMed ID: 1736770
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adjuvant xamoterol or metoprolol in patients with malignant ventricular arrhythmia resistant to amiodarone.
    Paul V; Griffith M; Ward DE; Camm AJ
    Lancet; 1989 Aug; 2(8658):302-5. PubMed ID: 2569105
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Slowing of ventricular tachycardia as a possible endpoint for serial drug testing at electrophysiological study.
    Handlin LR; Brodine WN; Gibbs H; Vacek JL
    Pacing Clin Electrophysiol; 1992 Jun; 15(6):864-9. PubMed ID: 1376898
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I; Saksena S; Krol RB; Munsif AN; Kolettis T; Mathew P; Varanasi S; Prakash A; Delfaut P; Lewis CB
    Am J Cardiol; 1997 Sep; 80(5B):3F-9F. PubMed ID: 9291444
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiologic evaluation of antiarrhythmic therapy for ventricular tachyarrhythmias.
    Kuchar DL; Garan H; Ruskin JN
    Am J Cardiol; 1988 Oct; 62(12):39H-45H. PubMed ID: 3052008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amiloride. Antiarrhythmic and electrophysiologic actions in patients with inducible sustained ventricular tachycardia.
    Duff HJ; Mitchell LB; Kavanagh KM; Manyari DE; Gillis AM; Wyse DG
    Circulation; 1989 Jun; 79(6):1257-63. PubMed ID: 2720927
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The role of Holter monitoring in patients with recurrent sustained ventricular tachycardia: an electrophysiologic correlation.
    Ezri MD; Huang SK; Denes P
    Am Heart J; 1984 Nov; 108(5):1229-36. PubMed ID: 6496281
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of combination therapy with mexiletine and a type IA agent for inducible ventricular tachyarrhythmias secondary to coronary artery disease.
    Greenspan AM; Spielman SR; Webb CR; Sokoloff NM; Rae AP; Horowitz LN
    Am J Cardiol; 1985 Aug; 56(4):277-84. PubMed ID: 4025166
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Propafenone-mexiletine combination for the treatment of sustained ventricular tachycardia.
    Yeung-Lai-Wah JA; Murdock CJ; Boone J; Kerr CR
    J Am Coll Cardiol; 1992 Sep; 20(3):547-51. PubMed ID: 1512331
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained ventricular tachycardia in patients with idiopathic dilated cardiomyopathy: electrophysiologic testing and lack of response to antiarrhythmic drug therapy.
    Poll DS; Marchlinski FE; Buxton AE; Doherty JU; Waxman HL; Josephson ME
    Circulation; 1984 Sep; 70(3):451-6. PubMed ID: 6744550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
    Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
    Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiarrhythmic drug exacerbation of ventricular tachycardia inducibility during electrophysiologic study.
    Sager PT; Perlmutter RA; Rosenfeld LE; Batsford WP
    Am Heart J; 1992 Apr; 123(4 Pt 1):926-33. PubMed ID: 1550002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term efficacy of mexiletine alone and in combination with class Ia antiarrhythmic drugs for refractory ventricular arrhythmias.
    Whitford EG; McGovern B; Schoenfeld MH; Garan H; Newell JB; McElroy M; Ruskin JN
    Am Heart J; 1988 Feb; 115(2):360-6. PubMed ID: 3341170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.